4 results match your criteria: "Weill Cornell Medical College of New York-Presbyterian Hospital[Affiliation]"
JAMA Ophthalmol
August 2014
Ophthalmic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York2Department of Ophthalmology, Weill Cornell Medical College, New York, New York.
Open Ophthalmol J
June 2014
Ophthalmic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA ; Department of Ophthalmology, Weill Cornell Medical College of New York-Presbyterian Hospital, New York, NY, USA.
There is growing interest in intravitreal injections of chemotherapy for retinoblastoma. However, concerns for potential tumor seeding through the needle track has prompted the use of risk-reducing precautionary methods. Presented here is a novel technique, which can be easily replicated, requires minimal sophisticated equipment and with laboratory data supporting its concept.
View Article and Find Full Text PDFPLoS One
December 2014
Ophthalmic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America ; Department of Ophthalmology, Mount Sinai School of Medicine, New York, New York, United States of America.
Purpose: To report electroretinogram responses of retinoblastoma children under anesthesia before and after treatment with chemotherapeutic drugs (melphalan, topotecan, carboplatin) delivery by ophthalmic artery chemosurgery (OAC).
Methods: A cohort study of 81 patients with retinoblastoma treated with OAC. All patients treated with OAC at our center through May 2012 for whom the requisite ERG data were available are included in the analysis.
PLoS One
March 2013
Service of Interventional Neuroradiology, Department of Neurosurgery, Weill Cornell Medical College of New York Presbyterian Hospital, New York, New York, United States of America.
Background: Intra-arterial (i.a.) chemotherapy has more risks of procedural complications in neonates and young infants.
View Article and Find Full Text PDF